The Analogue Advantage: A Smarter Way to derive the market uptake and New Product revenue Forecast
Background: Launching a new therapy in the oncology space is one of the most complex and challenging in the pharma and biotech industries. With evolving treatment landscapes, shifting market dynamics, and diverse patient journeys across geographies, forecasting future uptake has never been straightforward. One of our valued clients, a leading pharmaceutical company, approached Thelansis to develop a comprehensive global forecast for one of its later-stage pipeline assets targeting relapse and refractory cases within the oncology treatment setting. The client’s objective was to understand how similar products had performed in similar treatment and comparable market settings to devise strategic plans for launch, pricing, and lifecycle management. During initial discussions, it became clear that the client’s key priority was to identify suitable analogues, and this is where our Analogue Analysis Tool became central to the project. Objective: To build a robust, data-driven assump...